TABLE 4.

Investigator assessment of efficacy versus baseline MIC for Candida species in primary and salvage therapy studies 603, 608, 309/604, and 301/606

MIC breakpoint (μg/ml)Interpretive categoryNo. of isolates% Success
≤0.25S18977
0.5-2SDD3954
≥4R2162
≤0.5S21173
1-2SDD1765
≥4R2162
≤1S22174
2SDD743
≥4R2162